| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TRxADE HEALTH, INC | CFO, PAO, PFO | Common stock | 71.6K | $77.3K | $1.08 | Dec 13, 2022 | Direct |
| ORAGENICS INC | Chief Financial Officer | Employee Option (Right to Buy) | 80K | Sep 19, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OGEN | ORAGENICS INC | Sep 19, 2024 | 1 | $0 | 4 | Sep 20, 2024 | Chief Financial Officer |
| OGEN | ORAGENICS INC | Aug 8, 2023 | 1 | $0 | 4 | Aug 10, 2023 | CFO, Secretary and Treasurer |
| OGEN | ORAGENICS INC | Mar 7, 2023 | 1 | $0 | 4 | Mar 8, 2023 | CFO, Secretary and Treasurer |
| OGEN | ORAGENICS INC | Mar 7, 2023 | 0 | $0 | 3 | Mar 8, 2023 | CFO, Secretary and Treasurer |
| MEDS | TRxADE HEALTH, INC | Dec 13, 2022 | 1 | $0 | 4 | Feb 24, 2023 | CFO, PAO, PFO |
| MEDS | TRxADE HEALTH, INC | Sep 1, 2022 | 1 | $0 | 4 | Sep 16, 2022 | CFO, PAO, PFO |
| MEDS | TRxADE HEALTH, INC | Apr 2, 2022 | 0 | $0 | 3 | Apr 4, 2022 | CFO, PAO, PFO |